Culture

Members Face 'Catch-22' challenges joining online communities -- Ben-Gurion U. study

Ben-Gurion University Researchers Uncover a Catch-22 When It Comes to Social Media Online Support Groups and Privacy Concerns

BEER-SHEVA, Israel...February 16, 2021- People who seek support online social media groups may end up not getting the help they need due to privacy concerns, according to a new study by Ben-Gurion University of the Negev (BGU) and Gutenberg University in Sweden.

The new research, published in Social Media & Society, addresses the "Catch-22" challenges that face secure digital communities and their potential members, who, when faced with verifying their identity, may not join these groups for fear of sensitive issues becoming public.

"Social networks, and the technologies that support them, provide valuable tools for forming and maintaining connections that build social capital," says Dr. Daphna Yeshua-Katz of the BGU Department of Communication Studies. "While we don't dispute the benefits of these far-reaching communities, our findings reveal the problematic paradox caused by security concerns."

The researchers examined communications shared within support groups on several platforms, including eating disorder blogs, a fertility support forum for women, a Facebook group for bereaved parents, as well as WhatsApp groups for Israeli military veterans with post-traumatic stress disorder. After conducting in-depth interviews with dozens of community members and site managers, it became apparent that lack of anonymity and public visibility in social media platforms such as Facebook and WhatsApp can marginalize those who face social stigma.

For example, to gain access to their online social support groups, Facebook and WhatsApp algorithms force potential members to reveal aspects of their identity they may not wish to share, including real name, photo, profile, and phone number. Moreover, on Facebook, all users are required to disclose their list of friends and activities. These default settings may deter people who are not ready to reveal their identity.

"Online support communities must guard against imposters whose presence threatens a group's safe-haven," says Dr. Yeshua-Katz. "The challenge is to find a way to maintain community boundaries without going underground in a way that removes these groups from the public sphere and blocks access to those who need support."

Credit: 
American Associates, Ben-Gurion University of the Negev

A comparative study of surface hardness between two bioceramic materials

The placement of a wet cotton pellet against Mineral Trioxide Aggregate (MTA) is often recommended to ensure the completion of its setting reaction. This study aimed to evaluate the setting behaviour of MTA Angelus and NeoMTA by comparing their hardness after placing them in dry and moist conditions.

A simulated open apex was created on 40 polyvinyl tubes. The apical 4 mm of the tubes was filled with the two materials, NeoMTA Plus (Avalon Biomed Inc. Bradenton, FL, USA) and MTA Angelus (Angelus, Londrina, PR, Brazil) (n=20 per group). Both groups were subdivided into two subgroups based on the dry and wet conditions (n=10 per group). A wet cotton pellet was placed above the two materials in the wet group, and the coronal segment was sealed using Type II Glass ionomer cement (GC corporation Tokyo, Japan). Gutta-percha was placed against the test materials in the dry group with the coronal segment sealed with amalgam. Samples were placed in an oasis soaked in phosphate-buffered saline for seven days in 100% humidity and at 37°C.

Microhardness was measured independently at 4 and 2 mm from the apex. Hardness was compared between materials and conditions, applying analysis of variance (a = .05). The presence of dry or wet conditions had no significant effect on material hardness. MTA Angelus showed significantly higher hardness values compared with NeoMTA Plus. The moisture of the periapical environment can compensate for the absence of a wet cotton pellet and is adequate for the setting of the materials.

Credit: 
Bentham Science Publishers

The effects of picking up primary school pupils on surrounding street's traffic

The schools in Vietnam observe a phenomenon that almost all parents send their children to school using private vehicles, mostly motorcycles. The parents usually park their vehicle on streets outside the school gates which can cause serious congestion and chances of of traffic accidents.

This study aims to identify the factors affecting the picking up of pupils at primary school by analysing typical primary schools in Hanoi city. The researchers used the binary logistic regression model to determine the factors that influence the decision of picking up pupils and the waiting duration of parents. The behaviour of motorcyclists during the process was identified and studied in detail using the Kinovea software. Through the results the researchers found that, on the way back home, almost all the parents use motorbikes (89.15%) to pick up their children. During their waiting time (8.48 minutes on average), the parents did a lot of illegal parking activities on the streets which caused a lot of trouble, testing the other commuters, and created chances for potential accidents in front of the primary school entrance gate. Risky picking-up behaviours were observed in the research.

Based on the results, several traffic management measures have been proposed by the researchers to improve traffic safety and to reduce traffic congestion in front of school gates. In addition, the results of the study is expected to provide a useful reference for policymakers and authorities.

Credit: 
Bentham Science Publishers

Biotech fit for the Red Planet

image: A: Bioreactor Atmos ("Atmosphere Tester for Mars-bound Organic Systems"). B: A single vessel within Atmos. C: Design schematic

Image: 
C. Verseux / ZARM

NASA, in collaboration with other leading space agencies, aims to send its first human missions to Mars in the early 2030s, while companies like SpaceX may do so even earlier. Astronauts on Mars will need oxygen, water, food, and other consumables. These will need to be sourced from Mars, because importing them from Earth would be impractical in the long term. In Frontiers in Microbiology, scientists show for the first time that Anabaena cyanobacteria can be grown with only local gases, water, and other nutrients and at low pressure. This makes it much easier to develop sustainable biological life support systems.

"Here we show that cyanobacteria can use gases available in the Martian atmosphere, at a low total pressure, as their source of carbon and nitrogen. Under these conditions, cyanobacteria kept their ability to grow in water containing only Mars-like dust and could still be used for feeding other microbes. This could help make long-term missions to Mars sustainable," says lead author Dr Cyprien Verseux, an astrobiologist who heads the Laboratory of Applied Space Microbiology at the Center of Applied Space Technology and Microgravity (ZARM) of the University of Bremen, Germany.

Low-pressure atmosphere

Cyanobacteria have long been targeted as candidates to drive biological life support on space missions, as all species produce oxygen through photosynthesis while some can fix atmospheric nitrogen into nutrients. A difficulty is that they cannot grow directly in the Martian atmosphere, where the total pressure is less than 1% of Earth's - 6 to 11 hPa, too low for the presence of liquid water - while the partial pressure of nitrogen gas - 0.2 to 0.3 hPa - is too low for their metabolism. But recreating an Earth-like atmosphere would be expensive: gases would need to be imported, while the culture system would need to be robust - hence, heavy to freight - to resist the pressure differences: "Think of a pressure cooker," Verseux says. So the researchers looked for a middle ground: an atmosphere close to Mars's which allows the cyanobacteria to grow well.

To find suitable atmospheric conditions, Verseux et al. developed a bioreactor called Atmos (for "Atmosphere Tester for Mars-bound Organic Systems"), in which cyanobacteria can be grown in artificial atmospheres at low pressure. Any input must come from the Red Planet itself: apart from nitrogen and carbon dioxide, gases abundant in the Martian atmosphere, and water which could be mined from ice, nutrients should come from "regolith", the dust covering Earth-like planets and moons. Martian regolith has been shown to be rich in nutrients such as phosphorus, sulphur, and calcium.

Anabaena: versatile cyanobacteria grown on Mars-like dust

Atmos has nine 1 L vessels made of glass and steel, each of which is sterile, heated, pressure-controlled, and digitally monitored, while the cultures inside are continuously stirred. The authors chose a strain of nitrogen-fixing cyanobacteria called Anabaena sp. PCC 7938, because preliminary tests showed that it would be particularly good at using Martian resources and helping to grow other organisms. Closely related species have been shown to be edible, suitable for genetic engineering, and able to form specialized dormant cells to survive harsh conditions.

Verseux and his colleagues first grew Anabaena for 10 days under a mixture of 96% nitrogen and 4% carbon dioxide at a pressure of 100 hPa - ten times lower than on Earth. The cyanobacteria grew as well as under ambient air. Then they tested the combination of the modified atmosphere with regolith. Because no regolith has ever been brought from Mars, they used a substrate developed by the University of Central Florida (called "Mars Global Simulant") instead to create a growth medium. As controls, Anabaena were grown in standard medium, either at ambient air or under the same low-pressure artificial atmosphere.

The cyanobacteria grew well under all conditions, including in regolith under the nitrogen- and carbon dioxide-rich mixture at low pressure. As expected, they grew faster on standard medium optimized for cyanobacteria than on Mars Global Simulant, under either atmosphere. But this is still a major success: while standard medium would need to be imported from Earth, regolith is ubiquitous on Mars. "We want to use as nutrients resources available on Mars, and only those," says Verseux.

Dried Anabaena biomass was ground, suspended in sterile water, filtered, and successfully used as a substrate for growing of E. coli bacteria, proving that sugars, amino acids, and other nutrients can be extracted from them to feed other bacteria, which are less hardy but tried-and-tested tools for biotechnology. For example, E. coli could be engineered more easily than Anabaena to produce some food products and medicines on Mars that Anabaena cannot.

The researchers conclude that nitrogen-fixing, oxygen-producing cyanobacteria can be efficiently grown on Mars at low pressure under controlled conditions, with exclusively local ingredients.

Further refinements in the pipeline

These results are an important advance. But the authors caution that further studies are necessary: "We want to go from this proof-of-concept to a system that can be used on Mars efficiently," Verseux says. They suggest fine-tuning the combination of pressure, carbon dioxide, and nitrogen optimal for growth, while testing other genera of cyanobacteria, perhaps genetically tailored for space missions. A cultivation system for Mars also needs to be designed:

"Our bioreactor, Atmos, is not the cultivation system we would use on Mars: it is meant to test, on Earth, the conditions we would provide there. But our results will help guide the design of a Martian cultivation system. For example, the lower pressure means that we can develop a more lightweight structure that is more easily freighted, as it won't have to withstand great differences between inside and outside," concludes Verseux.

Credit: 
Frontiers

Hydrogen peroxide, universal oxidizing agent, high-efficiency production by simple process

image: Gold-platinum nanoparticle composite schematic

Image: 
Korea Institute of Science and Technology(KIST)

Hydrogen peroxide is used as a disinfectant, after dilution in water, to treat wounds. It is widely used across the industry as an eco-friendly oxidizing agent for impurity removal from semiconductors, waste treatment, etc. Currently, it is mainly produced by the sequential hydrogenation and oxidation of anthraquinone (AQ). However, this process is not only energy intensive and requires large-scale facilities, but AQ is also toxic.

As an alternative to the AQ process, hydrogen peroxide direct synthesis from hydrogen (H2) and oxygen (O2) using a palladium (Pd) catalyst was proposed. However, the commercialization of the technology has been challenging becausethe amount of water (H2O) formed is more than hydrogen peroxide (H2O2) during the process.*

*In the case of the Pd catalyst, 40% of hydrogen peroxide and 60% of water were maximally produced.

The Korea Institute of Science and Technology (KIST) announced that a joint research team of Dr. Sang Soo Han and Dr. Donghun Kim (Computational Science Research Center), Dr. Seung Yong Lee (Materials Architecture Research Center), and Professor Kwan-Young Lee at Korea University (Korea University, President Jin Taek Chung) developed a platinum-gold alloy catalyst for hydrogen peroxide production based on a computer simulation. Hydrogen peroxide selectivity can be increased to 95% by using this catalyst, compared with only 30-40% for a palladium catalyst, which indicates that mostly hydrogen peroxide on the developed Pt-Au catalyst can be produced with a small amount of water.

The joint research team between KIST and Korea University developed a new type of Pt-Au alloyed nanoparticle catalyst. Although it is difficult to homogeniously mix Pt and Au to develop an alloyed catalyst due to the intrinsic immiscibility of the metals, the researchers could successfully synthesize nanoparticles in the form of alloys by forcibly reducing **precursors of Pt and Au. Also, using this method, the content of each metal particle could be controlled by adjusting the amount of precursors of Pt and Au.

**Precursor: a substance from which the final specific substances is obtained by metabolism or chemical reactions

Hydrogen peroxide can be produced anywhere without large equipment by simply injecting both hydrogen gas and oxygen gas into an aqueous solution using the catalyst developed by the researchers. Unlike the Pd catalyst, the catalyst developed by the joint researchers can produce hydrogen peroxide up to 95% even at ambient temperature (10 ?C) and atmospheric pressure (1 atm). In addition, a catalytic reaction can be maintained for longer than 8 h, resulting from the structural stability of the catalyst.

The researchers clearly established the crystal structure of Pt-Au alloy nanoparticles by performing additional computer simulations, which is difficult to solve using general material analysis techniques. Furthermore, the catalytic reaction mechanism via compuater simulations was proposed at the atomic level in which the reason why the catalytic performance for hydrogen peroxide production is increased iswith increasing Au content was also clarified.

Sang Soo Han, Head of the Center at KIST, said, "it is important that the developed catalysts provide an eco-friendly hydrogen peroxide production option that can be applied without any limitation of manufacturing sites. Therefore, commercialization for the hydrogen peroxide direct synthesis would be greatly accelerated by overcoming the limitation of Pd catalysts with the low selectivity" and "the time and cost for the development of novel catalysts, mainly explored through trial and error, could be considerably reduced through computer simulations".

Credit: 
National Research Council of Science & Technology

Brief survey tool tracks symptoms, aids in evaluating effectiveness of treatment

image: Researchers from Regenstrief Institute and Indiana University School of Medicine have developed and validated a short, clinically practical questionnaire to help patients report symptoms and assist healthcare providers in assessing the severity of symptoms, and in monitoring and adjusting treatment accordingly.

Image: 
Regenstrief Institute

INDIANAPOLIS -- Researchers from Regenstrief Institute and Indiana University School of Medicine have developed and validated a short questionnaire to help patients report symptoms and assist healthcare providers in assessing the severity of symptoms, and in monitoring and adjusting treatment accordingly.

The tool, called SymTrak-8, is a shorter version of the SymTrak-23. The questionnaire tracks symptoms such as pain, fatigue, sleep disturbance, memory problems, anxiety and depression in older adults, enabling clinicians to provide better care for the diseases causing the symptoms.

"These symptoms are commonly reported in primary care, but they can be a sign of a variety of different diseases, so tracking them is important," said Kurt Kroenke, M.D., a Regenstrief Institute research scientist and IU School of Medicine professor of medicine. "This shorter version of Symtrak provides the same insight as the 23-question tool, but is less burdensome to complete. It could be very useful in busy primary care settings, where time can be limited."

The symptoms tracked by the tool can greatly impact quality of life, and they often appear in clusters as a result of multiple chronic conditions.

"The Symtrak-8 and Symtrak-23 provide a more complete picture of overall wellbeing and symptom burden," said Patrick O. Monahan, PhD, Regenstrief affiliated scientist and professor of biostatistics at IU School of Medicine. "The sensitivity of the questionnaires can be a good barometer of the efficacy of treatments."

The SymTrak tool draws upon strengths of existing questionnaires such as the PHQ-9, GAD-7, and PHQ-15, as well as PROMIS® (Patient-Reported Outcomes Measurement Information System) and the Healthy Aging Brain Care-Monitor. It can be filled out by a patient or a caregiver.

"We are excited about the scalability of these tools," said Dr. Kroenke. "They are clinically practical and clinically applicable, and the option of a shorter and longer version provides more flexibility for clinicians."

"SymTrak-8 as a Brief Measure for Assessing Symptoms in Older Adults" was published in the Journal of General Internal Medicine online ahead of print. This work was supported by National Institute on Aging grant R01 AG043465.

Credit: 
Regenstrief Institute

Mental health disorders and alcohol misuse more common in LGB people

Lesbian, gay and bisexual (LGB*) people are significantly more likely to have mental health conditions and report alcohol and drug misuse than heterosexual people - according to a new study led by UCL researchers in collaboration with the University of East Anglia and City, University of London.

The findings, published today in Psychological Medicine, come despite apparently more tolerant societal attitudes towards same-sex relationships.

Given this continued disparity, the report's authors are now calling for Government action to ensure equity in health and social care services. They highlight the need for improved awareness among health professionals to the mental health needs of sexual minority groups and are calling for policies that improve societal understanding, starting with encouraging schools to intervene earlier to encourage tolerant attitudes towards sexual minorities across the whole school community.

The research analysed data from the 2007 and 2014 Adult Psychiatric Morbidity Surveys** (APMS), which had a combined sample of 10,433 people in England aged 16-64.

The surveys are completed via face-to-face interviews and/or computer self-completion and contain data relating to sexual orientation, common mental disorders (CMD), hazardous alcohol use, and illicit drug use. Further information is collected on experiences of bullying and discrimination, religious identification and childhood sexual abuse.

In this analysis of 2007 and 2014 data the researchers found there had been no change (ie no improvement) between 2007 and 2014, with LGB people remaining at higher risk of poorer mental health when compared to heterosexuals.

The prevalence of depression and anxiety disorders among bisexual people was 40%, and for lesbian and gay people it was 28%, which was significantly higher than that for heterosexuals at 16%. Similarly, illicit drug use was highest among bisexual people, at 37%, while for lesbian and gay people it was 25% and heterosexuals, at 10.5%. Alcohol misuse was highest in lesbian and gay people, at 37%, compared with bisexual people at 31%, and heterosexuals, at 24%.

Researchers found evidence to suggest that exposure to bullying and discrimination may help explain the observed poorer mental health in lesbian women and gay men but not in bisexual people.

No evidence was found to support any apparent contribution of differences in religious affiliation or experiences of adversity such as childhood sexual abuse in the association between sexuality and mental health problems.

Lead author, Dr Alexandra Pitman (UCL Psychiatry), said: "What this study highlights is the significant and ongoing disparity in mental health between LGB people and heterosexual people, as evidenced by higher levels of mental health problems and alcohol and drug misuse.

"In order to reduce this persistent inequality in society, we must ensure that health and social care professionals are better trained to identify and care for the wellbeing and mental health needs of sexual minority groups, who are often made to feel invisible within national health systems.

"Furthermore, secondary schools must implement policies and practices that create supportive environments for sexual minority students, including providing (and actively promoting) access to a member of staff who is a designated minorities contact person, who students can talk to in confidence about experiences of discrimination, bullying, or mental health difficulties. Schools in the UK can also learn from positive experiences of Gay Straight Alliance (GSA) clubs in US high schools, where students benefit from access to a hub for socialising, support, and activism.

"More can also be also be done to implement anti-discrimination strategies and policies in health care institutions. This might include: the use of positive images of LGB people in health service marketing material; ensuring that equal opportunities statements include grounds of sexual orientation; taking a LGB-affirmative stance in psychotherapy (with implications for training of therapists); and training all professionals not to assume heterosexuality."

Senior author, Professor Michael King (UCL Psychiatry), said: "Our research shows that stigma and social exclusion on the basis of sexual orientation may be more subtle and enduring than we imagine. Despite greater public acceptance and legal changes to ensure equality, the lived experience of a proportion of LGB people remains negative. We would emphasise however that these data also show that the majority of LGB people have robust mental health and lead happy lives."

Co-author, Dr Joanna Semlyen (The University of East Anglia), said: "We know that sexual minorities are at increased risk of poor mental health than the heterosexual population. What this paper shows is that those inequalities did not change between the two study collection points of 2007 and 2014.

"This is really important because it shows that, despite some changes in societal attitudes, people who are lesbian, gay and bisexual continue to experience poor mental health.

"What we need to do now is not only continue to monitor health in sexual minority populations as standard but also to design studies to understand what causes these inequalities and develop interventions to reduce them."

Credit: 
University College London

MSK physician shares kidney cancer research at annual ASCO GU Symposium

Memorial Sloan Kettering Cancer Center (MSK) physicians and scientists presented new research at the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium held virtually February 11-13. Notably, MSK medical oncologist Robert Motzer, MD, presented encouraging data from a phase III randomized study that assessed two new treatment combinations as first-line treatments that may prolong survival in people with advanced kidney cancer. Dr. Motzer's findings were also published on February 13 in the New England Journal of Medicine.

In this large, international trial involving 200 sites across 20 countries, Dr. Motzer and a team of investigators evaluated two new regimens as first-line treatments for patients with advanced renal cell carcinoma (RCC) -- lenvatinib (Lenvima®) plus pembrolizumab (Keytruda®) and lenvatinib plus everolimus (Afinitor®) -- as compared with the current standard of care, sunitinib (Sutent®). They found that treatment with lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and a higher percentage of patients with an objective response versus sunitinib. Furthermore, results for overall survival were significantly longer in favor of lenvatinib plus pembrolizumab over sunitinib. Treatment with lenvatinib plus everolimus was also associated with a higher percentage of patients with an objective response and longer progression-free survival than sunitinib, but it did not have a significantly greater effect on overall survival.

"We are encouraged by all the data," said Dr. Motzer. "As physician-researchers, we consistently strive to provide our patients with the most effective therapies and give those with advanced disease more options. These results could lead to a change in the standard of care for these patients."

Dr. Motzer and colleagues concluded that lenvatinib plus pembrolizumab achieved significant improvements in progression-free survival, overall survival, and objective response rate versus sunitinib in the first-line treatment of patients with advanced renal cell carcinoma.

Continuing to Make Strides in Research for Kidney Cancer Patients

Cancer immunotherapy was born at MSK a little over a century ago. Since then, physician-scientists across MSK have led the effort to develop immune-based treatments for different types of cancer. MSK has been at the epicenter of discoveries in the field, and the institution's work is bringing exciting new treatment options to people around the world. MSK physicians have extensive experience using immunotherapy to treat people with melanoma, kidney cancer, lung cancer, and other cancers, as well as in handling immune-related side effects.

Despite available therapies for advanced metastatic kidney cancer, new options are needed to improve long-term disease control and patient survival. Without treatment, kidney cancer can be an aggressive disease. At the time of diagnosis, the cancer has already spread to other organs in approximately 30 percent of people, and about one-third of people whose disease is confined to the kidney will have a relapse. In 2021, it is estimated that over 73,000 new cases of RCC will be diagnosed and there will be nearly 15,000 deaths due to RCC in the United States -- and numbers are expected to rise significantly in the next decade.

"Over the years we have made very encouraging progress in our overall understanding and treatment of advanced kidney cancer; however, ongoing research is very crucial so we can give patients better treatment options to help manage their disease," said Dr. Motzer.

Credit: 
Memorial Sloan Kettering Cancer Center

How the immune system paves the way for SARS-CoV-2

image: Intestinal organoids: After treatment with IFN-?, the intestinal cells differentiate. The cell nuclei (blue) of the epithelial cells (green) localize at the basal (outer) edge of the organoids. This is accompanied by an increased production of the ACE2 receptor, which SARS-CoV-2 uses as a port of entry into the cells.

Image: 
Sigal Lab, Charité/MDC

Most people infected with SARS-CoV-2 are able to recover from the disease at home - even if they might experience very stressful disease progressions. Some have no symptoms at all. But about ten percent of those affected become so severely ill that they have to be treated in a hospital. The assumption that a weak immune system is behind a severe progression is short-sighted. Especially with critical progressions, the immune system works under intense pressure, but does not manage to control the virus.

A Berlin research group has now observed how SARS-CoV-2 uses an immune system defense mechanism to increasingly hijack the body's mucous membrane cells and multiply there. Their study has just appeared in the journal EMBO Molecular Medicine. "This may give us part of the explanation as to why the immune system has difficulty regulating or even defeating the infection in some people," says Dr. Julian Heuberger, scientist at the Division of Hepatology and Gastroenterology in Charité - Universitätsmedizin Berlin's Medical Department. He is the first author of the study and a member of an Emmy Noether Research Group led by PD Dr. Michael Sigal at Charité and the Berlin Institute for Medical Systems Biology (BIMSB), part of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC). For the study, the research group cooperated with researchers from the Max Planck Institute for Infection Biology (MPIIB), Freie Universität Berlin and Hong Kong University.

SARS-CoV-2 uses defense mechanism as a port of entry

Actually, the human body has a very effective defense mechanism against invaders, based on the interaction of various immune cells. T cells play an important role in this: When they encounter viruses in the organism, they destroy the affected cells. They also secrete the signaling molecule interferon-gamma (IFN-γ). On the one hand, IFN-γ fights infectious agents. On the other hand, it calls other immune cells to the scene.

Heuberger and his colleagues have now shown how SARS-CoV-2 can turn this protective mechanism mediated by IFN-γ into its opposite. For in addition to immune cells, the body's mucous membrane cells also respond to IFN-γ by forming more ACE2 receptors. SARS-CoV-2 needs these ACE2 receptors as a port of entry into the cells. Infected cells, in turn, make more ACE2. In this way, both the IFN-γ response of epithelial cells and the virus itself intensify the SARS-CoV-2 infection.

Cell differentiation observed in colon organoids

Patients infected with SARS-CoV-2 sometimes show gastrointestinal symptoms. In order to observe the immune cascade in the intestinal cells, Heuberger cultivated organoids of the human colon. An organoid is a kind of mini-organ in a petri dish, barely the size of a pinhead. The colon organoids are based on cells that come from intestinal biopsies. They grow in three-dimensionally arranged units and replicate the physiology of mucous membrane cells in the human intestinal tract. "These colon organoids are a very helpful tool," Heuberger emphasizes. "We can use them to explore the complex interplay of different signaling pathways that control cell differentiation from stem cells to specialized epithelial cells."

The scientists first treated the cultured intestinal cells with IFN-γ to simulate the body's immune response. Then they infected the organoids with SARS-CoV-2. Using gene expression analysis and a laser scanning microscope - a special optical microscope that scans a sample point by point - they were able to measure increased ACE2 expression in the organoids. In addition, quantitative polymerase chain reaction (PCR) detected increased virus production.

In other words, more IFN-γ means more ACE2. More ACE2 means more viruses can enter the cells. The more viruses that enter the cells, the more viruses produced. Thus, the immune response and the surface cell response to infection pave the way for SARS-CoV-2.

Balancing an excessive IFN-γ response with medication

"We hypothesize that a strong immune response may increase the susceptibility of mucous membrane cells to SARS-CoV-2," says the head of the study, Dr. Michael Sigal. He directs the Gastrointestinal Barrier, Regeneration and Carcinogenesis Lab at Charité and the MDC and is a gastroenterologist at Charité. "If the IFN-γ concentration is higher from the outset or the infection triggers a very excessive production of IFN-y, the viruses probably have an easier time entering the cells." However, the conditions under which this actually happens must still be investigated in clinical trials.

The results of the study carry the idea of a treatment approach for severe COVID-19 courses, Heuberger feels: "One possible strategy could be to balance the IFN-γ response with drugs." However, this would first require a very detailed analysis of the mechanisms underlying the IFN-γ response.

Credit: 
Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Story tips: Modeling COVID, permafrost lost and taking the heat

image: ORNL has modeled the spike protein that binds the novel coronavirus to a human cell for better understanding of the dynamics of COVID-19.

Image: 
Stephan Irle/ORNL, U.S. Dept. of Energy

Computing - Modeling COVID dynamics

To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.

These simulations also shed light on the ligand molecules that can inhibit such binding, pointing the way to potential drug therapies.

An ultrafast quantum chemical modeling method provides information about the critical electronic interactions between protein and ligand chemicals, going beyond the classical interaction models that are normally employed in computational drug discovery.

The findings will enable accurate predictions of the performance of currently available inhibitors and inform the future development of even more potent, novel inhibitor compounds, demonstrating the effectiveness of quantum chemical approaches in simulation for drug discovery.

"Quantum mechanics on supercomputers accelerates computational COVID-19 drug discovery by accurately describing inhibitor-virus protein interactions," said ORNL's Stephan Irle.

Media contact: Scott Jones, 865.241.6491, jonesg@ornl.gov

Image: https://www.ornl.gov/sites/default/files/2021-02/toc_notext.png

Caption: ORNL has modeled the spike protein that binds the novel coronavirus to a human cell for better understanding of the dynamics of COVID-19. Credit: Stephan Irle/ORNL, U.S. Dept. of Energy

Climate - Permafrost lost

A study by Oak Ridge National Laboratory, the University of Copenhagen, the National Park Service and the U.S. Geological Survey showed that hotter summers and permafrost loss are causing colder water to flow into Arctic streams, which could impact sensitive fish and other wildlife.

To understand trends observed in 11 Alaskan streams, ORNL researchers modeled the flow of water through the semi-frozen landscape during summer months. Usually, permafrost forms an icy barrier that keeps groundwater flow to the topmost layer of soil, which allows the water to warm with summer air temperatures.

Researchers found that as thawing permafrost sinks lower beneath the surface, groundwater flows deeper underground and, therefore, stays colder.

"In this ecosystem, the lateral flow of water strongly influences stream levels and temperatures," said ORNL's Scott Painter, "but it is often neglected in models. Our Amanzi-ATS model provides a detailed representation of the physics that impact groundwater supplying Arctic streams."

Media contact: Kim Askey, 865.576.2841, askeyka@ornl.gov

Image: https://www.ornl.gov/sites/default/files/2021-02/permafrost_melt_labeled.gif

Caption: ORNL researchers used the award-winning Amanzi-ATS model to simulate groundwater flow in Arctic ecosystems. As thawing permafrost sinks lower beneath the surface, groundwater flows deeper underground and, therefore, stays colder as it flow into streams. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

Manufacturing - Taking the heat

Oak Ridge National Laboratory researchers have demonstrated that a new class of superalloys made of cobalt and nickel remains crack-free and defect-resistant in extreme heat, making them conducive for use in metal-based 3D printing applications.

Metal materials have proven to be cost-effective for manufacturing, and deploying them for use in additive processes could enable the production of innovative, complex designs with minimal material waste. However, these materials are primarily used in energy, space and nuclear applications that also produce extreme heat environments.

In a study, researchers processed the cobalt and nickel class of superalloys and proved that they remained crack-free in electron-beam and laser-melting 3D printing processes.

"The challenge has been producing alloys that don't crack in the heat," ORNL's Mike Kirka said. "These superalloys have the material properties necessary for challenging environments, because they not only successfully withstood the heat but also retained strength when stretched."

Media contact: Jennifer Burke, 865.414.6835, burkejj@ornl.gov

Image: https://www.ornl.gov/sites/default/files/2021-02/2019-P05612-2.jpg

Caption: A 3D printed turbine blade demonstrates the use of the new class of nickel-based superalloys that can withstand extreme heat environments without cracking or losing strength. Credit: ORNL/U.S. Dept. of Energy

Credit: 
DOE/Oak Ridge National Laboratory

Cytoglobin: key player in preventing liver disease

image: 6His tagged recombinant human CYGB (His-CYGB) was endocytosed into the HSCs via Clathrin-mediated pathway, scavenged ROS, such as O2- and OH-, and induced IFN-β secretion mediated by TANK binding kinase 1 (TBK1), resulting in HSC deactivation and inhibition of αSMA and collagen gene expressions in vitro and in vivo. In total, His-CYGB could be utilized as anti-fibrotic therapy in human liver cirrhosis.

Image: 
Kawada/Osaka City University

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.

CYGB, discovered in 2001 by Professor Norifumi Kawada, is present in hepatic stellate cells, the cells that produce fibrotic molecules such as collagens when the liver has acute or chronic inflammation induced by different etiologies. The enhancement of CYGB on these cells or the injection of recombinant CYGB has the effect of suppressing liver damage and cirrhosis. These findings published in the February 2021 issue of the journal Hepatology.

Anti-fibrotic therapy remains an unmet medical need in human chronic liver diseases. A research team led by Professor Norifumi Kawada, Osaka City University (OCU), reported the novel anti-fibrotic properties of CYGB, a respiratory protein expressed in hepatic stellate cells (HSCs), the main cell type involved in liver fibrosis. In mice with advanced liver fibrosis, both enhancement of CYGB or recombinant CYGB injection can suppress hepatocyte damage and liver fibrosis. In chimera mice with a human liver, the injected CYGB did not show any adverse side effects.

"Fixing the liver after injury is a highly orchestrated, coordinated process, and inhibiting the fibrosis could return the liver to a healthy condition," said Norifumi Kawada, M.D., Ph.D., Dean of OCU Medical School and senior author of the study.

Liver injury starts with hepatocyte damage, following several conditions including inflammatory cell infiltration, activation of HSCs, and the production of harmful reactive oxygen species (ROSs). Dr. Kawada, along with Le Thi Thanh Thuy, PhD., OCU scientist, and their colleagues, observed that when they culture human HSCs under recombinant human CYGB treatment, it can enter the cellular organelles, hunt the harmful ROSs, and prevent the activation of HSCs leading to inhibit collagen production.

To identify potential treatment strategies, Dr. Kawada and his team developed several animal models of liver injury and investigated how the liver responds to CYGB regulation and treatment.

In both mouse models of bile flow obstruction induced cholestasis and high fat diet induced fatty liver disease, the absence of CYGB made the liver injury more severe, however, when CYGB was enhanced, the liver injury subsided.

In the next set of experiments, Dr. Kawada and his group tried to generate two other mouse models of advanced liver fibrosis using different chemical agents and applied recombinant human CYGB protein by intravenous injection. Interestingly, the therapeutic protein dramatically suppressed liver injuries, inflammation and fibrosis without any side effects.

Using the results of this research as a foothold, the research team hopes to start clinical trials using this new anti-fibrotic therapy.

Credit: 
Osaka City University

Switching to firm contracts may prevent natural gas fuel shortages at US power plants

Between January 2012 and March 2018, there were an average of 1,000 failures each year at large North American gas power plants due to unscheduled fuel shortages and fuel conservation interruptions. This is a problem as the power grid depends on reliable natural gas delivery from these power plants in order to function. More than a third of all U.S. electricity is generated from natural gas. New research now indicates that these fuel shortages are not due to failures of pipelines and that in certain areas of the country a change in how gas is purchased can significantly reduce generator outages.

The paper, "What Causes Natural Gas Fuel Shortages at U.S. Power Plants?" by researchers at Carnegie Mellon University and the North American Electric Reliability Corporation, was published in Energy Policy.

Gas shortages at generators have caused simultaneous failures of several power plants. Physical failures and disruptions of the natural gas pipeline network are rare; the authors found that they account for no more than 5% of the power plant generation lost to fuel shortages over the six years examined. The vast majority of the natural gas generator outages due to fuel unavailability were due to curtailment of gas when supplies were tight. In the Midwest and Mid-Atlantic states, natural gas was available but power plants that did not purchase firm contracts were out-prioritized by commercial and industrial customers.

"While it is unsurprising that plants using the spot market or interruptible pipeline contracts for their fuel were somewhat more likely to experience fuel shortages than those with firm contracts, these contracts can still make a big difference in reliability in certain regions," says Jay Apt, a Professor and the Co-Director of Carnegie Mellon's Electricity Industry Center, who co-authored the paper. "Still, firm contracts are not a solution for areas such as New England that have few gas pipelines and further discussion on other mitigation strategies should be explored."

Natural gas is increasingly used to generate power in the U.S. and the North American Electric Reliability Corporation (NERC) projects that the natural gas generating capacity will further expand by 12 GW over the next decade, about a 5% increase. Fuel shortages have been a problem at power plants that are used exclusively at times of peak demand, such as during extreme cold and hot weather, as well as at more heavily-used gas power plants. This indicates that fuel shortages affect the power grid's ability to operate whether it's responding to an emergency or merely serving load during normal operation.

Previous research has focused on technical reports from reliability organizations or regional transmission organizations. For the first time, researchers for this paper used historical data collected by NERC to examine fuel shortages between 2012 and 2018 at natural gas power plants in North America to determine their cause. The researchers' primary goal was to identify how many of these fuel shortage failures were caused by physical interruptions of gas flow as opposed to operational procedures on the pipeline network, such as gas service curtailment priority. They also sought to respond to policy questions regarding whether generators could mitigate fuel shortage failures by switching to firm pipeline contracts.

Along with analyzing the NERC data from 2012 - 2018, the researchers developed a systematic approach to match the NERC failure data to U.S. Energy Information Administration generator characteristic data in order to evaluate how gas pipeline system characteristics have historically affected natural gas fuel shortage failures. They calculated a time series of unscheduled, unavailable capacity due to fuel shortages and time-matched the beginning times of fuel shortage power plant failure events with time windows of pipeline failures to determine if pipeline failures could have caused fuel shortage outages at power plants. They then completed a similar process of spatial matching of power plants to gas trading hubs in order to assess the historical availability of natural gas for transactions by power plants.

Ultimately, the researchers observed that both plants with firm contracts and plants without firm contracts experienced fuel shortages and conservation interruptions, but that non-firm plants were overrepresented in the fuel shortage failure data. This suggests that curtailment priority on pipeline networks is the likely reason for most correlated failures. However, the data also suggests that firm contracts will not solve everything and other strategies should be explored, especially in areas such as New England where the pipeline network has historically been constrained.

Credit: 
Carnegie Mellon University

Targeting Nsp1 protein could be a pathway for COVID-19 therapy

DALLAS - Feb. 16, 2021 - A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.

Since the start of the pandemic, scientists have worked endlessly to understand SARS-CoV-2, the coronavirus that causes COVID-19. Even with the arrival of vaccines, the virus is still spreading and there is a need to develop alternative therapies. Scientists hope to achieve this by studying how SARS-CoV-2 infects cells and propagates itself while avoiding the body's natural immune system.

Now researchers at UT Southwestern have added another piece to this puzzle with their study published in Science Advances.

"When a virus infects a cell, the way the host cell reacts is to alter cellular pathways (or networks) in certain ways to counteract the viral infection. Viruses can target many of these pathways to favor their own replication," says Beatriz Fontoura, Ph.D., professor of cell biology at UTSW and corresponding author of the paper.

Viruses replicate by suppressing the host cell's genes in favor of their own. One way they do this is by blocking the export of messenger RNA (mRNA) from the nucleus of the cell to another compartment called the cytoplasm. Some of these RNAs code for proteins that can only be made by the cell in the cytoplasm. So, by blocking their export from the nucleus, viruses prevent some proteins from being made (e.g., antiviral proteins) and simultaneously free up the cell's machinery for their own replication.

"We've been studying the NS1 protein of the influenza virus and we have shown that one of its functions is to block mRNA nuclear export. Due to some similarities between NS1 from flu and Nsp1 from coronaviruses in their roles in suppressing antiviral response in the host cell, we decided to test whether these two proteins shared a similar function," says Ke Zhang, Ph.D., a postdoctoral researcher in Fontoura's lab and first author of the paper.

The researchers landed on the protein Nsp1. Coronavirus Nsp1 has been described as a multifunctional protein capable of altering viral replication and suppressing the production of other proteins, some of which are involved in immune response. Fontoura's group sought to find out how Nsp1 does this and if it uses a mechanism similar to that of the influenza virus protein NS1.

Indeed, the group found that like NS1 from influenza, SARS-CoV-2 Nsp1 inhibits host cell mRNA nuclear export by binding to the export factor NXF1. This new role of Nsp1 complements the protein's other function, blocking host cell mRNA translation into protein. By obstructing two steps that lead to the production of proteins, Nsp1 suppresses a cell's ability to respond to the viral infection, allowing SARS-CoV-2 to replicate. So what would happen, researchers wondered, if Nsp1 could be stopped from performing one of these functions?

In a proof-of-principle experiment, the researchers infected cells with SARS-CoV-2 and added an excess of NXF1 to see if this would block virus replication. Strikingly, that's exactly what they found. When the cells had access to more NXF1 than the SARS-CoV-2 virus could suppress, the cells were able to stop the virus from multiplying.

The study offers insight into the mechanism behind how coronaviruses, and SARS-CoV-2 in particular, are able to promote their replication inside host cells. Understanding this mechanism provides a building block for potential therapeutics.

"If you find a way to block the interaction between Nsp1 and NXF1 or increase the amount of NXF1 in the cell, you'll get mRNAs out of the nucleus and may get a protective effect, as suggested by our experiments," says Fontoura.

COVID-19 treatments focus on management of symptoms while the body fights off the infection with its natural defenses. A key area of interest in viral therapies is to target the infected cells to stop the virus from replicating. Focusing on Nsp1 or its interaction with NXF1 represents a possible way to do this.

"We still need to know more, like the structure of Nsp1 bound to NXF1, which would shed light on how this blocks mRNA export and how we can revert it," says Zhang. "The research is promising, but in order to develop therapies down the line, we first need to better understand the mechanism."

Credit: 
UT Southwestern Medical Center

Harmful alcohol use rising during pandemic, UArizona Health Sciences researchers say

image: William "Scott " Kilgore, PhD

Image: 
Photo: University of Arizona Health Sciences

TUCSON, Ariz. -- The ongoing pandemic has had a significant and alarming trend of increased alcohol use and abuse - especially among younger adults, males and those who have lost their jobs - according to a new study by University of Arizona Health Sciences researchers.

Research led by William "Scott" Killgore, PhD, professor of psychiatry in the UArizona College of Medicine - Tucson and director of the Social, Cognitive and Affective Neuroscience Lab, found that hazardous alcohol use and likely dependence increased every month for those under lockdowns compared to those not under restrictions.

"Being under lockdown during a worldwide pandemic has been hard on everyone, and many people are relying on greater quantities of alcohol to ease their distress," said Dr. Killgore. "We found that younger people were the most susceptible to increased alcohol use during the pandemic, which could set them on the dangerous path toward long-term alcohol dependence."

The paper, "Alcohol dependence during COVID-19 lockdowns," was recently published in the journal Psychiatry Research.

Between April and September 2020, Dr. Killgore and UArizona co-authors Sara Cloonan, Emily Taylor, Daniel Lucas and Natalie Dailey, PhD, surveyed 5,931 adults from all 50 states and the District of Columbia. Each month, roughly 1,000 participants completed the Alcohol Use Disorders Identification Test (AUDIT), a 10-item questionnaire that is used to detect hazardous drinking in adults.

The questions assess the frequency and quantity of alcohol consumed, behaviors associated with dependence, and harm resulting from alcohol use, and provide scores that range from 0 to 40. Scores from 8 to 14 suggest hazardous or harmful alcohol consumption, a score of 15 or more indicates the likelihood of alcohol dependence, and a score of 20 or more implies severe alcohol use disorder.

People under lockdown posted increases for all three thresholds, with hazardous alcohol use rising from 21.0% in April to 40.7% in September and probable alcohol dependence rising from 7.9% to 29.1%. For those scoring 20 or higher, usage that is considered severe alcohol dependence, percentages for those under lockdown increased from 3.9% in April to 17.4% by September.

For all three thresholds, the percentages for those not under lockdown restrictions were essentially unchanged.

Dr. Killgore says the surge in alcohol use comes with several risks, not only to the individual, but also to the family.

"Being cooped up with family for weeks and months without a break can be difficult, but when excess alcohol gets mixed in, it can become a recipe for increased aggressive behavior and domestic violence," Dr. Killgore said. "I worry about the effect on families and children."

For the individual, there are numerous health problems associated with alcohol dependence, including risks of cancer, liver disease, injury, mental health problems and early death. Additionally, employers may also be affected by an individual's excessive alcohol use.

"Many of us are working from home, but this is not the same thing as being productive from home. The use of alcohol while 'on the job' at home is likely to reduce productivity at a time when the country needs us to be doing everything we can to sustain the economy," he added. "Having a few drinks while 'on the clock' at home can lead to a situation of 'presenteeism,' which means that a person may be sitting through Zoom meetings and responding to a few emails, but may not actually be contributing productively to their job. This could severely hamper our ability to pull out of this crisis quickly and on a strong economic footing."

Credit: 
University of Arizona Health Sciences

Supercomputer turns back cosmic clock

image: Schematic diagram of the evolution of the Universe from the inflation (left) to the present (right). The "reconstruction method" winds back the evolution from right to left on this illustration to reproduce the primordial density fluctuations from the current galaxy distribution.

Image: 
Institute of Statistical Mathematics

Astronomers have tested a method for reconstructing the state of the early Universe by applying it to 4000 simulated universes using the ATERUI II supercomputer at the National Astronomical Observatory of Japan (NAOJ). They found that together with new observations the method can set better constraints on inflation, one of the most enigmatic events in the history of the Universe. The method can shorten the observation time required to distinguish between various inflation theories.

Just after the Universe came into existence 13.8 billion years ago, it suddenly increased more than a trillion, trillion times in size, in less than a trillionth of a trillionth of a microsecond; but no one knows how or why. This sudden "inflation," is one of the most important mysteries in modern astronomy. Inflation should have created primordial density fluctuations which would have affected the distribution of where galaxies developed. Thus, mapping the distribution of galaxies can rule out models for inflation which don't match the observed data.

However, processes other than inflation also impact galaxy distribution, making it difficult to derive information about inflation directly from observations of the large-scale structure of the Universe, the cosmic web comprised of countless galaxies. In particular, the gravitationally driven growth of groups of galaxies can obscure the primordial density fluctuations.

A research team led by Masato Shirasaki, an assistant professor at NAOJ and the Institute of Statistical Mathematics, thought to apply a "reconstruction method" to turn back the clock and remove the gravitational effects from the large-scale structure. They used ATERUI II, the world's fastest supercomputer dedicated to astronomy simulations, to create 4000 simulated universes and evolve them through gravitationally driven growth. They then applied this method to see how well it reconstructed the starting state of the simulations. The team found that their method can correct for the gravitational effects and improve the constraints on primordial density fluctuations.

"We found that this method is very effective," says Shirasaki. "Using this method, we can verify of the inflation theories with roughly one tenth the amount of data. This method can shorten the required observing time in upcoming galaxy survey missions such as SuMIRe by NAOJ's Subaru Telescope."

Credit: 
National Institutes of Natural Sciences